← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2009Last known activity
Jun 14, 2019
Timeline
1990s
- Jan 1, 1996
Polyphor Ltd.— Founded
Drugs by trial phase (14 distinct, 12 trials)
Phase 3 (13 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Bronchiectasis
- Fibrosis
- Healthcare-Associated Pneumonia
- Hodgkin Disease
- Infarction
- Infections
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Myocardial Infarction
- Neoplasms, Plasma Cell
- Pneumonia
- Pneumonia, Ventilator-Associated
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pseudomonas Infections
- Renal Insufficiency
- Respiratory Tract Infections
- ST Elevation Myocardial Infarction
Recent trials (12)
- NCT03786094Lead sponsorPhase 3Jun 14, 2019
- NCT03582007Lead sponsorPhase 3Sep 30, 2018
- NCT03409679Lead sponsorPhase 3Mar 23, 2018
- NCT02897869Lead sponsorPhase 1Apr 1, 2016
- NCT02096315Lead sponsorPhase 2Dec 1, 2013
- NCT02096328Lead sponsorPhase 2Oct 1, 2013
- NCT01905475Lead sponsorPhase 2Jul 1, 2013
- NCT01837095Lead sponsorPhase 1Jun 1, 2013
- NCT02110459Lead sponsorPhase 1Apr 1, 2013
- NCT01413568Lead sponsorPhase 1/Phase 2Apr 1, 2012
- NCT01841476Lead sponsorPhase 1Feb 1, 2012
- NCT01105403Lead sponsorPhase 2Apr 1, 2009
Details
- Founded
- Allschwil, CH Jan 1, 1996
- Last known activity
- Jun 14, 2019